SCHEMBL260436

SCHEMBL260436

CCCCCCC(C)OC(=O)c1ccc([N+](=O)[O-])cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.52
MGLL Q99685 2/20 0.47
HDAC3 O15379 1/20 0.47
HDAC1 Q13547 1/20 0.47
HDAC2 Q92769 1/20 0.47
ADRB2 P07550 1/20 0.46
ADRB1 P08588 1/20 0.46
ADRB3 P13945 1/20 0.46
SLC6A2 P23975 1/20 0.46
SLC6A4 P31645 1/20 0.46
SLC6A3 Q01959 1/20 0.46
L3MBTL1 Q9Y468 3/20 0.46
MAPT P10636 5/20 0.45
ATM Q13315 1/20 0.45
TSHR P16473 1/20 0.44
POLB P06746 1/20 0.44
CRHBP P24387 2/20 0.43
CRHR2 Q13324 2/20 0.43
ALOX12 P18054 1/20 0.43
PNKP Q96T60 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29052458 1.00 ALDH1A1 (0.52) ALDH1A1MGLLHDAC3HDAC1HDAC2
SCHEMBL29051938 1.00 ALDH1A1 (0.52) ALDH1A1MGLLHDAC3HDAC1HDAC2
SCHEMBL1142097 1.00 ALDH1A1 (0.52) ALDH1A1MGLLHDAC3HDAC1HDAC2
SCHEMBL17941247 0.99 ALDH1A1 (0.50) ALDH1A1MGLLHDAC3HDAC1HDAC2
SCHEMBL25612582 0.95 HDAC3 (0.49) ALDH1A1MGLLHDAC3HDAC1HDAC2
SCHEMBL1704751 0.87 ALDH1A1 (0.64) ALDH1A1L3MBTL1MAPTTSHRKMT2A
SCHEMBL12537417 0.86 ALDH1A1 (0.49) ALDH1A1MGLLHDAC3HDAC1HDAC2
SCHEMBL9979054 0.84 PRKCA (0.50) ALDH1A1MGLLHDAC3HDAC1HDAC2
SCHEMBL28344393 0.84 ADRB2 (0.50) ALDH1A1ADRB2ADRB1ADRB3MAPT
SCHEMBL14273580 0.83 ALDH1A1 (0.59) ALDH1A1L3MBTL1MAPTTSHRKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2112136-B1 BIS(2-ALKOXYETHYL) AZODICARBOXYLATE ESTER COMPOUND AND INTERMEDIATE FOR PRODUCTION OF THE SAME TOYO BOSEKI (JP) 2012-05-23 EP disclosed
US-8067440-B2 Phosphonium salts derivatives and uses thereof VALORISATION-RECHERCHE, LIMITED PARTNERSHIP (CA) 2011-11-29 US disclosed
US-7947816-B2 Azodicarboxylic acid bis(2-alkoxyethyl) ester compound, and production intermediate thereof TOYO BOSEKI KABUSHIKI KAISHA (JP) 2011-05-24 US disclosed
US-20110092683-A1 PHOSPHONIUM SALTS DERIVATIVES AND USES THEREOF VALORISATION-RECHERCHE, LIMITED PARTNERSHIP (CA) 2011-04-21 US disclosed
US-20110028701-A1 AZODICARBOXYLIC ACID BIS(2-ALKOXYETHYL) ESTER COMPOUND, AND PRODUCTION INTERMEDIATE THEREOF TOYOBO MC CORPORATION (JP) 2011-02-03 US disclosed
US-7880037-B2 Phosphonium supported triphenylphosphine; for controlling solubility of a molecule; oxidation of Cinnamyl Alcohol using above catalyst system VALORISATION-RECHERCHE, LIMITED PARTNERSHIP (CA) 2011-02-01 US disclosed
US-7880037-B2 Phosphonium supported triphenylphosphine; for controlling solubility of a molecule; oxidation of Cinnamyl Alcohol using above catalyst system VALORISATION-RECHERCHE, LIMITED PARTNERSHIP (CA) 2011-02-01 US disclosed
US-7820802-B2 Azodicarboxylic acid bis(2-alkoxyethyl) ester compound, and production intermediate thereof TOYOBO MC CORPORATION (JP) 2010-10-26 US disclosed
US-20100048881-A1 AZODICARBOXYLIC ACID BIS(2-ALKOXYETHYL) ESTER COMPOUND, AND PRODUCTION INTERMEDIATE THEREOF TOYO KASEI KOGYO CO., LTD. (JP) 2010-02-25 US disclosed
EP-2112136-A1 BIS(2-ALKOXYETHYL) AZODICARBOXYLATE ESTER COMPOUND AND INTERMEDIATE FOR PRODUCTION OF THE SAME TOYO KASEI KOGYO COMPANY LIMITED (JP) 2009-10-28 EP disclosed
US-20070197477-A1 PHOSPHONIUM SALTS DERIVATIVES VALORISATION-RECHERECHE (CA) 2007-08-23 US disclosed
US-20070197477-A1 PHOSPHONIUM SALTS DERIVATIVES VALORISATION-RECHERECHE (CA) 2007-08-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110028701-A1 AZODICARBOXYLIC ACID BIS(2-ALKOXYETHYL) ESTER COMPOUND, AND PRODUCTION INTERMEDIATE THEREOF CPS1, MCCC2, PC ALDH1A1 554/4885MGLL 1857/4885HDAC3 3160/4885
US-20070197477-A1 PHOSPHONIUM SALTS DERIVATIVES PI4K2A, PIP4K2A, PI4K2B ALDH1A1 3806/4885MGLL 4756/4885HDAC3 2399/4885
US-20110092683-A1 PHOSPHONIUM SALTS DERIVATIVES AND USES THEREOF PI4K2A, PIP4K2A, PI4K2B ALDH1A1 3468/4885MGLL 4589/4885HDAC3 2586/4885
US-20100048881-A1 AZODICARBOXYLIC ACID BIS(2-ALKOXYETHYL) ESTER COMPOUND, AND PRODUCTION INTERMEDIATE THEREOF CPS1, MCCC2, PC ALDH1A1 554/4885MGLL 1857/4885HDAC3 3160/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.